Profound Medical Corp.
PROF
$6.32
-$0.11-1.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 88.15% | -20.73% | |||
| Total Other Revenue | 160.47% | -13.33% | |||
| Total Revenue | 139.21% | -15.64% | |||
| Cost of Revenue | 129.01% | -22.79% | |||
| Gross Profit | 142.95% | -12.68% | |||
| SG&A Expenses | -20.37% | 13.58% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.33% | 16.17% | |||
| Operating Income | 35.44% | -23.64% | |||
| Income Before Tax | 49.74% | -46.32% | |||
| Income Tax Expenses | 89.06% | 56.10% | |||
| Earnings from Continuing Operations | 49.17% | -46.35% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 49.17% | -46.35% | |||
| EBIT | 35.44% | -23.64% | |||
| EBITDA | 35.85% | -24.19% | |||
| EPS Basic | 49.25% | -46.27% | |||
| Normalized Basic EPS | 49.83% | -46.24% | |||
| EPS Diluted | 49.25% | -46.27% | |||
| Normalized Diluted EPS | 49.83% | -46.24% | |||
| Average Basic Shares Outstanding | 0.17% | 0.04% | |||
| Average Diluted Shares Outstanding | 0.17% | 0.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||